All News #Library
Biotech
Anokion Completes Enrollment in ACeD-it, SynCeD Ph 2 Trials
19 Dec 2024 //
BUSINESSWIRE
Anokion Presents ANK-700 Data For Multiple Sclerosis
18 Sep 2024 //
BUSINESSWIRE
Anokion`s KAN-101 Supports Celiac Disease-Modifying Potential
20 May 2024 //
BUSINESSWIRE
Anokion to Participate in BofA Healthcare Trailblazers Conference
19 Oct 2023 //
BUSINESSWIRE
Anokion Announces Clinical Progress with KAN-101 and ANK-700
12 Sep 2023 //
BUSINESSWIRE
Anokion Announces Publication Safety and Preliary Effects of KAN-101
15 Jun 2023 //
BUSINESSWIRE
Anokion Announces New Data from the Phase 1 ACeD Trial Supporting KAN-101
09 May 2023 //
BUSINESSWIRE

Market Place
Sourcing Support